U.S. Global Investors, Inc. (GROW)

Revance Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	26.26	27.4	25.4	22.31	14.44	1.94
Short-Term Investments	9.69	9.64	11.64	12.14	6.32	6.32
Cash & Short-Term Investments	35.95	37.04	37.04	34.45	20.76	8.26
Cash Growth	-4.20%	-	7.52%	65.97%	151.37%	-12.96%
Accounts Receivable	1.03	1.05	1.25	1.8	2.53	0.97
Other Receivables	0.66	0.73	0.58	0.38	2.15	-
Receivables	1.7	1.78	1.82	2.18	4.68	0.97
Prepaid Expenses	0.65	0.5	0.51	0.4	0.35	0.29
Restricted Cash	1	1	1	1	1	1.03
Total Current Assets	39.3	40.32	40.37	38.03	26.79	10.54
Property, Plant & Equipment	1.13	1.19	1.2	1.46	1.42	1.6
Long-Term Investments	6.23	8.42	11.96	17.78	33.97	6.58
Long-Term Deferred Tax Assets	1.9	1.83	1.92	0.87	-	-
Long-Term Deferred Charges	-	0	0	0.01	0	0.01
Other Long-Term Assets	0.2	0.2	0.21	0.21	0.1	0.09
Total Assets	48.76	51.96	55.67	58.36	62.28	18.82
Accounts Payable	0	0.01	0.14	0.07	0.1	0.03
Accrued Expenses	1.44	1.73	2.36	3.6	2.91	1.38
Short-Term Debt	-	-	-	-	-	0.44
Current Portion of Leases	0.02	0.03	0.03	0.03	0.04	0.05
Current Income Taxes Payable	0.06	0.08	0.08	0.1	1.88	-
Other Current Liabilities	0.3	0.31	0.33	0.34	0.23	0.11
Total Current Liabilities	1.81	2.16	2.94	4.13	5.15	2.01
Long-Term Leases	-	0.01	0.04	0.07	-	0.04
Long-Term Deferred Tax Liabilities	0.01	-	0	-	2.8	-
Total Liabilities	1.82	2.17	2.98	4.2	7.95	2.05
Common Stock	0.4	0.4	0.4	0.4	0.4	0.4
Additional Paid-In Capital	16.5	16.44	16.44	16.44	15.68	15.62
Retained Earnings	36.41	37.46	37.57	35.92	33.83	2.63
Treasury Stock	-7.39	-5.88	-3.74	-2.6	-2.17	-1.88
Comprehensive Income & Other	0.18	0.58	1.35	3.62	6.59	-0
Total Common Equity	46.1	49.01	52.02	53.79	54.32	16.76
Minority Interest	0.84	0.79	0.67	0.38	-	-
Shareholders' Equity	46.94	49.79	52.69	54.16	54.32	16.76
Total Liabilities & Equity	48.76	51.96	55.67	58.36	62.28	18.82
Total Debt	0.02	0.04	0.07	0.09	0.04	0.54
Net Cash (Debt)	35.94	37	36.98	34.36	20.72	7.72
Net Cash Growth	-4.13%	0.07%	7.62%	65.86%	168.22%	-18.59%
Net Cash Per Share	2.65	2.61	2.53	2.29	1.37	0.51
Filing Date Shares Outstanding	13.15	13.68	14.31	14.95	15.02	15.08
Total Common Shares Outstanding	13.22	13.82	14.57	14.96	15.04	15.08
Working Capital	37.49	38.15	37.44	33.9	21.64	8.53
Book Value Per Share	3.49	3.55	3.57	3.60	3.61	1.11
Tangible Book Value	46.1	49.01	52.02	53.79	54.32	16.76
Tangible Book Value Per Share	3.49	3.55	3.57	3.60	3.61	1.11
Buildings	-	4.67	4.62	4.61	4.61	4.6
Machinery	-	1.13	0.98	0.99	0.87	0.85

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q